Regeneron Pharmaceuticals, Inc.
TUBULYSINS AND PROTEIN-TUBULYSIN CONJUGATES
Last updated:
Abstract:
Provided herein are compounds, compositions, and methods for the treatment of diseases and disorders associated with cancer, including tubulysins and protein (e.g., antibody) drug conjugates thereof.
Status:
Application
Type:
Utility
Filling date:
20 Dec 2019
Issue date:
26 Aug 2021